Table 1.
Strategies | Evidence level* |
Pre antimalarial treatment considerations | |
Smoking cessation | 2B |
Photoprotection: SPF 70 or greater, sun-protective clothing, UV avoidance | 1B |
Possible Polypodium leucotomos supplementation | 5 |
Medication compliance | |
Measure HCQ drug levels after ≥2 months | 1B |
Full daily doses instead of split doses | 5 |
GI upset: switch to nightly HCQ dosing, titrate HCQ gradually | 5 |
*Evidence levels adapted from the Oxford Centre for Evidence-Based Medicine.
CLE, cutaneous lupus erythematosus; GI, gastrointestinal; HCQ, hydroxychloroquine; SPF, sun protection factor; UV, ultraviolet.